Mark Alan Goldberg Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Mark Alan Goldberg.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Mark Alan Goldberg. Mark Alan Goldberg is Director in IMMUNOGEN INC ($IMGN) and Director in IDERA PHARMACEUTICALS, INC. ($IDRA) and Director in GLYCOMIMETICS INC ($GLYC) and Director in aTYR PHARMA INC ($LIFE) and Director in Blueprint Medicines Corp ($BPMC) and Director in Audentes Therapeutics, Inc. ($BOLD).
Latest Insider Trading Transactions of Mark Alan Goldberg
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, LIFE, BOLD, BPMC, GLYC, IDRA, IMGN
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 27 2021 | GLYC | GLYCOMIMETICS INC | Goldberg Mark Alan | Director | Option Exercise | A | 2.55 | 10,500 | 26,775 | 10,500 | |
| May 27 2021 | GLYC | GLYCOMIMETICS INC | Goldberg Mark Alan | Director | Grant | A | 0.00 | 5,250 | 0 | 5,250 | 0 to 5.3 K |
| Apr 02 2021 | IMGN | ImmunoGen, Inc. | Goldberg Mark Alan | Director | Option Exercise | A | 0.00 | 1,666 | 0 | 109,876 | |
| Jan 06 2021 | IDRA | IDERA PHARMACEUTIC ... | Goldberg Mark Alan | Director | Grant | A | 4.02 | 3,452 | 13,877 | 38,099 | 34.6 K to 38.1 K (+9.96 %) |
| Jan 04 2021 | IMGN | ImmunoGen, Inc. | Goldberg Mark Alan | Director | Option Exercise | A | 0.00 | 2,093 | 0 | 108,210 | |
| Dec 28 2020 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Option Exercise | M | 28.15 | 5,455 | 153,558 | 0 | |
| Dec 28 2020 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Sell | S | 125.00 | 5,455 | 681,875 | 3,562 | 9 K to 3.6 K (-60.50 %) |
| Dec 28 2020 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Buy | M | 28.15 | 5,455 | 153,558 | 9,017 | 3.6 K to 9 K (+153.14 %) |
| Dec 22 2020 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Option Exercise | M | 28.15 | 5,454 | 153,530 | 5,455 | |
| Dec 22 2020 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Sell | S | 120.00 | 5,454 | 654,480 | 3,562 | 9 K to 3.6 K (-60.49 %) |
| Dec 22 2020 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Buy | M | 28.15 | 5,454 | 153,530 | 9,016 | 3.6 K to 9 K (+153.12 %) |
| Dec 15 2020 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Option Exercise | M | 28.15 | 5,455 | 153,558 | 10,909 | |
| Dec 15 2020 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Sell | S | 115.00 | 5,455 | 627,325 | 3,562 | 9 K to 3.6 K (-60.50 %) |
| Dec 15 2020 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Buy | M | 28.15 | 5,455 | 153,558 | 9,017 | 3.6 K to 9 K (+153.14 %) |
| Dec 03 2020 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Option Exercise | M | 28.15 | 5,454 | 153,530 | 16,364 | |
| Dec 03 2020 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Sell | S | 110.00 | 5,454 | 599,940 | 3,562 | 9 K to 3.6 K (-60.49 %) |
| Dec 03 2020 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Buy | M | 28.15 | 5,454 | 153,530 | 9,016 | 3.6 K to 9 K (+153.12 %) |
| Oct 21 2020 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Option Exercise | M | 19.53 | 5,455 | 106,536 | 0 | |
| Oct 21 2020 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Sell | S | 105.00 | 5,455 | 572,775 | 3,562 | 9 K to 3.6 K (-60.50 %) |
| Oct 21 2020 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Buy | M | 19.53 | 5,455 | 106,536 | 9,017 | 3.6 K to 9 K (+153.14 %) |
| Oct 05 2020 | IDRA | IDERA PHARMACEUTIC ... | Goldberg Mark Alan | Director | Grant | A | 2.25 | 6,166 | 13,874 | 34,647 | 28.5 K to 34.6 K (+21.65 %) |
| Oct 01 2020 | IMGN | ImmunoGen, Inc. | Goldberg Mark Alan | Director | Option Exercise | A | 0.00 | 3,750 | 0 | 106,117 | |
| Jul 02 2020 | IDRA | IDERA PHARMACEUTIC ... | Goldberg Mark Alan | Director | Grant | A | 1.79 | 7,751 | 13,874 | 28,481 | 20.7 K to 28.5 K (+37.39 %) |
| Jul 02 2020 | IMGN | ImmunoGen, Inc. | Goldberg Mark Alan | Director | Option Exercise | A | 0.00 | 2,934 | 0 | 102,367 | |
| Jun 26 2020 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Option Exercise | A | 76.24 | 4,500 | 343,080 | 4,500 | |
| Jun 26 2020 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Grant | A | 0.00 | 2,250 | 0 | 3,562 | 1.3 K to 3.6 K (+171.49 %) |
| Jun 23 2020 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Option Exercise | M | 0.00 | 1,312 | 0 | 0 | |
| Jun 23 2020 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Buy | M | 0.00 | 1,312 | 0 | 1,312 | 0 to 1.3 K |
| Jun 18 2020 | IMGN | ImmunoGen, Inc. | Goldberg Mark Alan | Director | Option Exercise | A | 4.56 | 50,000 | 228,000 | 50,000 | |
| Jun 18 2020 | IMGN | ImmunoGen, Inc. | Goldberg Mark Alan | Director | Option Exercise | A | 0.00 | 17,000 | 0 | 99,433 | |
| May 27 2020 | GLYC | GLYCOMIMETICS INC | Goldberg Mark Alan | Director | Option Exercise | A | 3.00 | 21,000 | 63,000 | 21,000 | |
| May 19 2020 | IDRA | IDERA PHARMACEUTIC ... | Goldberg Mark Alan | Director | Option Exercise | A | 1.97 | 11,500 | 22,655 | 11,500 | |
| Apr 03 2020 | IDRA | IDERA PHARMACEUTIC ... | Goldberg Mark Alan | Director | Grant | A | 1.28 | 10,730 | 13,734 | 20,730 | 10 K to 20.7 K (+107.30 %) |
| Apr 02 2020 | IMGN | ImmunoGen, Inc. | Goldberg Mark Alan | Director | Option Exercise | A | 0.00 | 3,958 | 0 | 82,433 | |
| Apr 02 2020 | IMGN | ImmunoGen, Inc. | Goldberg Mark Alan | Director | Option Exercise | A | 0.00 | 3,958 | 0 | 82,433 | |
| Jan 15 2020 | BOLD | Audentes Therapeut ... | Goldberg Mark Alan | Director | Option Exercise | D | 24.74 | 16,200 | 400,788 | 0 | |
| Jan 15 2020 | BOLD | Audentes Therapeut ... | Goldberg Mark Alan | Director | Option Exercise | D | 38.65 | 10,000 | 386,500 | 0 | |
| Jan 15 2020 | BOLD | Audentes Therapeut ... | Goldberg Mark Alan | Director | Option Exercise | D | 38.00 | 4,500 | 171,000 | 0 | |
| Jan 15 2020 | BOLD | Audentes Therapeut ... | Goldberg Mark Alan | Director | Option Exercise | D | 33.91 | 18,000 | 610,380 | 0 | |
| Jan 15 2020 | BOLD | Audentes Therapeut ... | Goldberg Mark Alan | Director | Sell | U | 60.00 | 1,500 | 90,000 | 0 | 1.5 K to 0 (-100.00 %) |
| Jan 02 2020 | IMGN | ImmunoGen, Inc. | Goldberg Mark Alan | Director | Option Exercise | A | 0.00 | 2,641 | 0 | 78,475 | |
| Oct 02 2019 | IMGN | ImmunoGen, Inc. | Goldberg Mark Alan | Director | Option Exercise | A | 0.00 | 5,578 | 0 | 75,834 | |
| Jul 01 2019 | IMGN | IMMUNOGEN INC | Goldberg Mark Alan | Director | Option Exercise | A | 0.00 | 6,221 | 0 | 70,256 | |
| Jun 24 2019 | IMGN | IMMUNOGEN INC | Goldberg Mark Alan | Director | Option Exercise | A | 2.10 | 18,000 | 37,800 | 18,000 | |
| Jun 24 2019 | IMGN | IMMUNOGEN INC | Goldberg Mark Alan | Director | Option Exercise | A | 0.00 | 4,000 | 0 | 64,035 | |
| Jun 20 2019 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Option Exercise | A | 0.00 | 1,312 | 0 | 1,312 | |
| Jun 20 2019 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Option Exercise | A | 96.77 | 4,875 | 471,754 | 4,875 | |
| Jun 06 2019 | IDRA | IDERA PHARMACEUTIC ... | Goldberg Mark Alan | Director | Option Exercise | A | 2.57 | 11,500 | 29,555 | 11,500 | |
| May 21 2019 | GLYC | GLYCOMIMETICS INC | Goldberg Mark Alan | Director | Option Exercise | A | 12.39 | 21,000 | 260,190 | 21,000 | |
| Apr 01 2019 | IMGN | IMMUNOGEN INC | Goldberg Mark Alan | Director | Option Exercise | A | 0.00 | 4,981 | 0 | 60,035 | |
| Feb 08 2019 | BOLD | Audentes Therapeut ... | Goldberg Mark Alan | Director | Option Exercise | A | 24.74 | 16,200 | 400,788 | 16,200 | |
| Jan 02 2019 | IMGN | IMMUNOGEN INC | Goldberg Mark Alan | Director | Option Exercise | A | 0.00 | 2,812 | 0 | 55,054 | |
| Dec 20 2018 | IDRA | IDERA PHARMACEUTIC ... | Goldberg Mark Alan | Director | Buy | P | 3.19 | 10,000 | 31,897 | 10,000 | 0 to 10 K |
| Nov 07 2018 | IMGN | IMMUNOGEN INC | Goldberg Mark Alan | Director | Buy | P | 5.76 | 30,000 | 172,800 | 53,800 | 23.8 K to 53.8 K (+126.05 %) |
| Oct 01 2018 | IMGN | IMMUNOGEN INC | Goldberg Mark Alan | Director | Option Exercise | A | 0.00 | 1,425 | 0 | 52,242 | |
| Jul 02 2018 | IMGN | IMMUNOGEN INC | Goldberg Mark Alan | Director | Option Exercise | A | 0.00 | 1,227 | 0 | 50,817 | |
| Jun 25 2018 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Option Exercise | A | 69.79 | 7,500 | 523,425 | 51,136 | |
| Jun 22 2018 | IDRA | IDERA PHARMACEUTIC ... | Goldberg Mark Alan | Director | Option Exercise | A | 1.53 | 50,000 | 76,500 | 50,000 | |
| Jun 22 2018 | IMGN | IMMUNOGEN INC | Goldberg Mark Alan | Director | Option Exercise | A | 11.21 | 18,000 | 201,780 | 18,000 | |
| Jun 22 2018 | IMGN | IMMUNOGEN INC | Goldberg Mark Alan | Director | Option Exercise | A | 0.00 | 4,000 | 0 | 49,590 | |
| Jun 08 2018 | BOLD | Audentes Therapeut ... | Goldberg Mark Alan | Director | Option Exercise | A | 38.65 | 10,000 | 386,500 | 10,000 | |
| May 21 2018 | GLYC | GLYCOMIMETICS INC | Goldberg Mark Alan | Director | Option Exercise | A | 18.41 | 11,000 | 202,510 | 11,000 | |
| Apr 02 2018 | IMGN | IMMUNOGEN INC | Goldberg Mark Alan | Director | Option Exercise | A | 0.00 | 1,118 | 0 | 45,590 | |
| Jan 19 2018 | BOLD | Audentes Therapeut ... | Goldberg Mark Alan | Director | Option Exercise | A | 38.00 | 4,500 | 171,000 | 4,500 | |
| Jan 19 2018 | BOLD | Audentes Therapeut ... | Goldberg Mark Alan | Director | Option Exercise | A | 33.91 | 18,000 | 610,380 | 18,000 | |
| Jan 03 2018 | IMGN | IMMUNOGEN INC | Goldberg Mark Alan | Director | Option Exercise | A | 0.00 | 1,833 | 0 | 44,472 | |
| Oct 03 2017 | IMGN | IMMUNOGEN INC | Goldberg Mark Alan | Director | Option Exercise | A | 0.00 | 1,535 | 0 | 42,639 | |
| Jul 03 2017 | IMGN | IMMUNOGEN INC | Goldberg Mark Alan | Director | Option Exercise | A | 0.00 | 1,652 | 0 | 41,104 | |
| Jun 23 2017 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Option Exercise | A | 46.02 | 10,909 | 502,032 | 43,636 | |
| Jun 15 2017 | IMGN | IMMUNOGEN INC | Goldberg Mark Alan | Director | Option Exercise | A | 4.64 | 10,000 | 46,400 | 10,000 | |
| Jun 15 2017 | IMGN | IMMUNOGEN INC | Goldberg Mark Alan | Director | Option Exercise | A | 0.00 | 3,000 | 0 | 39,452 | |
| Jun 09 2017 | IDRA | IDERA PHARMACEUTIC ... | Goldberg Mark Alan | Director | Option Exercise | A | 1.63 | 50,000 | 81,500 | 50,000 | |
| May 30 2017 | GLYC | GLYCOMIMETICS INC | Goldberg Mark Alan | Director | Option Exercise | A | 13.89 | 11,000 | 152,790 | 11,000 | |
| May 11 2017 | LIFE | aTYR PHARMA INC | Goldberg Mark Alan | Director | Option Exercise | A | 3.15 | 20,000 | 63,000 | 20,000 | |
| Apr 04 2017 | IMGN | IMMUNOGEN INC | Goldberg Mark Alan | Director | Option Exercise | A | 0.00 | 3,036 | 0 | 36,452 | |
| Jan 03 2017 | IMGN | IMMUNOGEN INC | Goldberg Mark Alan | Director | Option Exercise | A | 0.00 | 5,759 | 0 | 33,416 | |
| Dec 15 2016 | IMGN | IMMUNOGEN INC | Goldberg Mark Alan | Director | Buy | P | 1.80 | 20,000 | 36,000 | 23,800 | 3.8 K to 23.8 K (+526.32 %) |
| Dec 13 2016 | IMGN | IMMUNOGEN INC | Goldberg Mark Alan | Director | Option Exercise | A | 1.84 | 5,000 | 9,200 | 5,000 | |
| Dec 13 2016 | IMGN | IMMUNOGEN INC | Goldberg Mark Alan | Director | Option Exercise | A | 0.00 | 1,500 | 0 | 27,657 | |
| Oct 03 2016 | IMGN | IMMUNOGEN INC | Goldberg Mark Alan | Director | Option Exercise | A | 0.00 | 4,384 | 0 | 26,157 | |
| Jul 06 2016 | IMGN | IMMUNOGEN INC | Goldberg Mark Alan | Director | Option Exercise | A | 0.00 | 3,814 | 0 | 21,773 | |
| Jun 27 2016 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Option Exercise | A | 19.53 | 10,909 | 213,053 | 32,727 | |
| Jun 15 2016 | IDRA | IDERA PHARMACEUTIC ... | Goldberg Mark Alan | Director | Option Exercise | A | 1.44 | 35,000 | 50,400 | 35,000 | |
| May 26 2016 | LIFE | aTYR PHARMA INC | Goldberg Mark Alan | Director | Option Exercise | A | 3.33 | 18,000 | 59,940 | 18,000 | |
| May 19 2016 | GLYC | GLYCOMIMETICS INC | Goldberg Mark Alan | Director | Option Exercise | A | 6.35 | 11,000 | 69,850 | 11,000 | |
| Apr 04 2016 | IMGN | IMMUNOGEN INC | Goldberg Mark Alan | Director | Option Exercise | A | 0.00 | 1,379 | 0 | 17,959 | |
| Mar 07 2016 | GLYC | GLYCOMIMETICS INC | Goldberg Mark Alan | Director | Buy | P | 4.77 | 10,397 | 49,630 | 11,497 | 1.1 K to 11.5 K (+945.18 %) |
| Jan 29 2016 | LIFE | aTYR PHARMA INC | Goldberg Mark Alan | Director | Option Exercise | A | 6.14 | 19,428 | 119,288 | 19,428 | |
| Nov 12 2015 | IMGN | IMMUNOGEN INC | Goldberg Mark Alan | Director | Option Exercise | A | 13.07 | 10,000 | 130,700 | 10,000 | |
| Nov 12 2015 | IMGN | IMMUNOGEN INC | Goldberg Mark Alan | Director | Option Exercise | A | 0.00 | 3,000 | 0 | 16,580 | |
| Aug 11 2015 | GLYC | GLYCOMIMETICS INC | Goldberg Mark Alan | Director | Option Exercise | A | 7.50 | 11,000 | 82,500 | 11,000 | |
| Jul 10 2015 | LIFE | aTYR PHARMA INC | Goldberg Mark Alan | Director | Option Exercise | A | 14.96 | 6,286 | 94,039 | 6,286 | |
| Jun 10 2015 | IDRA | IDERA PHARMACEUTIC ... | Goldberg Mark Alan | Director | Option Exercise | A | 3.59 | 35,000 | 125,650 | 35,000 | |
| Nov 12 2014 | IMGN | IMMUNOGEN INC | Goldberg Mark Alan | Director | Option Exercise | A | 10.10 | 10,000 | 101,000 | 10,000 | |
| Nov 12 2014 | IMGN | IMMUNOGEN INC | Goldberg Mark Alan | Director | Option Exercise | A | 0.00 | 3,000 | 0 | 13,580 | |
| Nov 13 2013 | IMGN | IMMUNOGEN INC | Goldberg Mark Alan | Director | Option Exercise | A | 14.70 | 10,000 | 147,000 | 10,000 | |
| Nov 13 2013 | IMGN | IMMUNOGEN INC | Goldberg Mark Alan | Director | Option Exercise | A | 0.00 | 3,000 | 0 | 3,000 | |
| Nov 15 2012 | IMGN | IMMUNOGEN INC | Goldberg Mark Alan | Director | Option Exercise | A | 11.42 | 4,645 | 53,046 | 4,645 | |
| Nov 15 2012 | IMGN | IMMUNOGEN INC | Goldberg Mark Alan | Director | Option Exercise | A | 0.00 | 2,626 | 0 | 2,626 | |
| Nov 09 2012 | IMGN | IMMUNOGEN INC | Goldberg Mark Alan | Director | Buy | P | 11.27 | 3,000 | 33,804 | 3,800 | 800 to 3.8 K (+375.00 %) |
Page: 1